Clinical trials
Enrolling by invitation Phase 3 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 2 |
| Sanofi | 2 |
| UCB Biopharma SRL | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Astria Therapeutics, Inc. | 1 |
| Avidity Biosciences, Inc. | 1 |
| BioMarin Pharmaceutical | 1 |
| Eli Lilly and Company | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angioedemas, Hereditary | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Amyloidosis | 1 |
| Angioedema | 1 |
| Asthma | 1 |
| Connective Tissue Diseases | 1 |
| Dermatitis, Atopic | 1 |
| Dermatomyositis | 1 |
| Eczema | 1 |
| Epilepsies, Myoclonic | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.